Search Results - "Galvão, Violeta Regnier"

Risk stratification and skin testing to guide re-exposure in taxane-induced hypersensitivity reactions by Picard, Matthieu, MD, Pur, Leyla, MD, Caiado, Joana, MD, Giavina-Bianchi, Pedro, MD, PhD, Galvão, Violeta Regnier, MD, Berlin, Suzanne T., DO, Campos, Susana M., MD, Matulonis, Ursula A., MD, Castells, Mariana C., MD, PhD

“…Background The optimal approach to patients with hypersensitivity reactions (HSRs) to taxanes has not been established. Objective We sought to assess the…”
Get full text

Current Knowledge and Management of Hypersensitivity Reactions to Monoclonal Antibodies by Picard, Matthieu, MD, Galvão, Violeta Régnier, MD

“…Hypersensitivity reactions (HSRs) to monoclonal antibodies (mAbs) are increasingly frequent as this class of therapeutic agents is rapidly expanding. Immediate…”
Get full text

Hypersensitivity to Biological Agents—Updated Diagnosis, Management, and Treatment by Galvão, Violeta Régnier, MD, Castells, Mariana C., MD, PhD

“…Biological agents are used in the treatment of neoplastic, autoimmune, and inflammatory diseases and their clinical applications are becoming broader…”
Get full text

Basophil Activation Test Is a Relevant Biomarker of the Outcome of Rapid Desensitization in Platinum Compounds-Allergy by Giavina-Bianchi, Pedro, MD, PhD, Galvão, Violeta Régnier, MD, Picard, Matthieu, MD, Caiado, Joana, MD, Castells, Mariana C., MD, PhD

“…Background Rapid drug desensitization (RDD) has become a cornerstone in the management of immediate drug hypersensitivity reactions (DHRs) to chemotherapeutic…”
Get full text

BAT in the Diagnosis of Drug Allergy: a Novel Tool in Clinical Daily Practice? by Campos, Lucila, Galvão, Violeta Régnier, Kalil, Jorge, Castells, Mariana, Giavina-Bianchi, Pedro

“…Purpose of Review The aim of this study is to critically review the relevant literature published on basophil activation test, presenting the current knowledge…”
Get full text

Carboplatin-allergic patients undergoing desensitization: prevalence and impact of the BRCA 1/2 mutation by Galvão, Violeta Régnier, MD, Phillips, Elizabeth, MD, Giavina-Bianchi, Pedro, MD, PhD, Castells, Mariana C., MD, PhD

“…Deleterious germline BRCA 1/2 mutation was described as an independent risk factor for carboplatin hypersensitivity reactions (HSRs).1 In 2013, Moon et al1…”
Get full text

Perioperative Anaphylaxis by Galvão, Violeta Régnier, Giavina-Bianchi, Pedro, Castells, Mariana

“…Perioperative anaphylaxis is a life-threatening condition with an estimated prevalence of 1:3,500 to 1:20,000 procedures and a mortality rate of up to 9 %…”
Get full text

Monoclonal Antibodies Hypersensitivity: Prevalence and Management by Santos, Rafael Bonamichi, Galvão, Violeta Régnier

“…The use of monoclonal antibodies (mAbs) has become broader because of their recognized effectiveness in the treatment of autoimmune, neoplastic, and…”
Get full text

Clinical and laboratory improvement after intravenous immunoglobulin in drug reaction with eosinophilia and systemic symptoms by Galvão, Violeta Régnier, MD, Aun, Marcelo Vivolo, MD, Kalil, Jorge, MD, PhD, Castells, Mariana, MD, PhD, Giavina-Bianchi, Pedro, MD, PhD

“…Regarding DRESS, IVIG antibodies may function to neutralize the virus4; however, this is only speculation because no other studies have shown this effect until…”
Get full text

Safety and Immunogenicity of LY3415244, a Bispecific Antibody Against TIM-3 and PD-L1, in Patients With Advanced Solid Tumors by Hellmann, Matthew D, Bivi, Nicoletta, Calderon, Boris, Shimizu, Toshio, Delafontaine, Brant, Liu, Zhuqing Tina, Szpurka, Anna M, Copeland, Victoria, Hodi, F Stephen, Rottey, Sylvie, Aftimos, Philippe, Piao, Yongzhe, Gandhi, Leena, Galvao, Violeta Regnier, Leow, Ching Ching, Doi, Toshihiko

“…Investigate the safety and efficacy of LY3415244, a TIM-3/PD-L1 bispecific antibody that blocks TIM-3 and PD-L1 in patients with advanced solid tumors. A phase…”
Get full text

Blocking TIM-3 in Treatment-refractory Advanced Solid Tumors: A Phase Ia/b Study of LY3321367 with or without an Anti-PD-L1 Antibody by Harding, James J, Moreno, Victor, Bang, Yung-Jue, Hong, Min Hee, Patnaik, Amita, Trigo, José, Szpurka, Anna M, Yamamoto, Noboru, Doi, Toshihiko, Fu, Siqing, Calderon, Boris, Velez de Mendizabal, Nieves, Calvo, Emiliano, Yu, Danni, Gandhi, Leena, Liu, Zhuqing Tina, Galvao, Violeta Regnier, Leow, Ching Ching, de Miguel, Maria J

“…T-cell immunoglobulin and mucin-domain-containing molecule-3 (TIM-3) blunts anticancer immunity and mediates resistance to programmed death 1 (PD-1) and PD…”
Get full text

Symmetrical drug-related intertriginous and flexural exanthema (SDRIFE): two atypical case reports by Longen, Eduardo, D'onofrio-Silva, Ana Carolina, Aun, Marcelo Vivolo, Ribeiro, Marisa Rosimeire, Garro, Laila Sabino, Kalil, Jorge, Bianchi, Pedro Giavina, Motta, Antonio Abílio, Galvão, Violeta Regnier

Get full text

Monoclonal Antibodies Hypersensitivity by Santos, Rafael Bonamichi, Galvão, Violeta Régnier

“…The use of monoclonal antibodies (mAbs) has become broader because of their recognized effectiveness in the treatment of autoimmune, neoplastic, and…”
Get full text

Erythema multiforme induced by clindamycin diagnosed by patch test by Saliba, Bruna Gama, Simis, Nathalia Pessoa, Ribeiro, Marisa Rosimeire, Garro, Laila Sabino, Portilho, Nathália Coelho, Kalil, Jorge, Giavina-Bianchi, Pedro, Motta, Antonio Abílio, Aun, Marcelo Vivolo, Galvão, Violeta Regnier

Get full text

Rapid Desensitization in Immediate Hypersensitivity Reaction to Drugs by Giavina-Bianchi, Pedro, Aun, Marcelo Vivolo, Galvão, Violeta Régnier, Castells, Mariana

“…Opinion Statement Adverse drug reactions have increased dramatically worldwide, often preventing the use of first-line therapies. Not infrequently, many…”
Get full text

Basophil activation test in allergic patients to platins undergoing rapid desensitization by Giavina‐Bianchi, Pedro, Caiado, Joana, Picard, Matthieu, Galvão, Violeta Régnier, Castells, Mariana

Get full text